Skip to content

Real world study of Huoluo Xiaotong capsule in treating cervical spondylosis of nerve root type (wind-cold Bi obstruction syndrome/Qi stagnation blood stasis syndrome)

Real world study of Huoluo Xiaotong capsule in treating cervical spondylosis of nerve root type (wind-cold Bi obstruction syndrome/Qi stagnation blood stasis syndrome)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092027
Enrollment
Unknown
Registered
2024-11-07
Start date
2024-05-30
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve root type cervical spondylosis (syndrome of wind-cold BI/Syndrome of Qi stagnation and blood stasis)

Interventions

Observation group (Huoluo Xiaotong capsule):None
Control group (Jingtong granule):None

Sponsors

The First Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) In line with Western diagnostic criteria for cervical radiculopathy; (2) TCM syndrome differentiation for wind-cold arthralgia or qi stagnation and blood stasis; (3) Age =18 years old, gender is not limited; (4) Huoluo Xiaotong capsules or Jugtong granules were used in this prescription (but no other traditional Chinese medicine preparations for the treatment of cervical spondylosis were used); (5) Participate in the study voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Cervical spondylosis patients with cervical type, spinal type, vertebral artery type and sympathetic nerve type as the main symptoms; (2) Women who are breastfeeding, pregnant or have a pregnancy plan in the near future; (3) patients with severe heart disease or gastric ulcer; (4) Patients requiring combined surgical treatment; (5) Can not cooperate with the completion of information collection or the researcher thinks that it is not suitable to participate in the researcher.

Design outcomes

Primary

MeasureTime frame
NRS score;

Secondary

MeasureTime frame
Traditional Chinese Medicine each individual symptom;Traditional Chinese Medicine Syndrome Integral Curative Effect;

Countries

China

Contacts

Public ContactQing Chen

The First Affiliated Hospital of Hunan University of Chinese Medicine

3124617441@qq.com+86 137 8714 2874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026